7.34 USD
↗ 0.05 (0.69%)AT CLOSE (11:59 AM EDT)
LENZ Therapeutics, Inc. Common Stock
LENZNASDAQ • USD
7.26
↘ 0.09 (1.16%)
POST MARKET (AS OF 07:50 PM EDT)
Post Market
AS OF 07:50 PM EDT
7.26
↘ 0.09 (1.16%)
Market: CLOSED
Open?$7.18
High?$7.42
Low?$6.86
Prev. Close?$7.29
Volume?994.3K
Avg. Volume?814.8K
VWAP?$7.09
Rel. Volume?1.22x
Bid / Ask
Bid?$7.00 × 2.0K
Ask?$7.44 × 500
Spread?$0.44
Midpoint?$7.22
Valuation & Ratios
Market Cap?230.1M
Shares Out?31.4M
Float?18.2M
Float %?58.2%
P/E Ratio?N/A
P/B Ratio?0.93
EPS?-$3.47
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
Employees
152
Market Cap
230.1M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2024-03-22
Address
201 LOMAS SANTA FE DRIVE, SUITE 300
SOLANA BEACH, CA 92075
Phone: 858-925-7000
SOLANA BEACH, CA 92075
Phone: 858-925-7000
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?10.40Strong
Quick Ratio?10.26Strong
Cash Ratio?0.96Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?0.93CHEAP▾
P/S?10.96HIGH▾
P/FCF?N/A▾
EV/EBITDA?-1.7CHEAP▾
EV/Sales?9.78HIGH▾
Returns & Efficiency
ROE?-44.2%WEAK▾
ROA?-40.0%WEAK▾
Cash Flow & Enterprise
FCF?$-87438000
Enterprise Value?$205.4M
Fundamentals ratios updated end of day